EMA Authorised: Trabectedin Accord (trabectedin) — Accord Healthcare S.L.U.

View source ↗

Summary

The European Medicines Agency authorised Accord Healthcare's trabectedin (Trabectedin Accord) for use in sarcoma and ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Sarcoma

Drugs mentioned

• Trabectedin Accord (trabectedin)

Snippet

Status: Authorised. Therapeutic area: Sarcoma;Ovarian Neoplasms. MAH: Accord Healthcare S.L.U.. Decision date: 24/03/2026